Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Arthritis

Study Title

Laquinimod Study in Systemic Lupus Erythematosus (SLE) Patients With Active Lupus Arthritis

Teva Identifier

LA-LAQ-202

ClinicalTrials.gov Identifier

NCT01085084

Study Status

Completed

Trial Condition(s)

Lupus Arthritis

Interventions

Drug: Laquinimod | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
inflammation and infections icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 75 Years

Trial Duration

07/01/2010 - 10/01/2012

Phase

Phase 2

Study Type

Interventional